Factors XI and XII as Targets for New Anticoagulants

por Weitz, Jeffrey I., Fredenburgh, James C.
Publicado 2017

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants

por Weitz, Jeffrey I., Jaffer, Iqbal H., Fredenburgh, James C.
Publicado 2017

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function

por Yeh, Calvin H., Stafford, Alan R., Leslie, Beverly A., Fredenburgh, James C., Weitz, Jeffrey I.
Publicado 2016

Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation

por Jaffer, Iqbal H, Stafford, Alan R, Fredenburgh, James C, Whitlock, Richard P, Chan, Noel C, Weitz, Jeffrey I
Publicado 2015

Histidine-rich glycoprotein attenuates catheter thrombosis

por Malik, Rida A., Liao, Peng, Zhou, Ji, Hussain, Rawaa, Fredenburgh, James C., Hettrick, Lisa, Revenko, Alexey S., Weitz, Jeffrey I.
Publicado 2023

Identification and characterization of a factor Va-binding site on human prothrombin fragment 2

por Friedmann, Alexander P., Koutychenko, Anatoli, Wu, Chengliang, Fredenburgh, James C., Weitz, Jeffrey I., Gross, Peter L., Xu, Ping, Ni, Feng, Kim, Paul Y.
Publicado 2019

Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation

por Kim, Paul Y., Yeh, Calvin H., Dale, Brian J., Leslie, Beverly A., Stafford, Alan R., Fredenburgh, James C., Hirsh, Jack, Weitz, Jeffrey I.
Publicado 2018